Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2006-11-19
pubmed:abstractText
To investigate the effects of sex hormones on ethanol (EtOH)-induced bone loss, female Sprague-Dawley rats were fed control or EtOH-containing diets (12 g/kg/day) by intragastric infusion. After 3 weeks, rats receiving EtOH had significant decreases in tibial trabecular and total bone mineral density, induction of receptor activator of nuclear factor-kappaB ligand (RANKL) mRNA expression, and enhanced bone resorption, all of which were prevented by treatment with 17beta-estradiol (E(2)). The addition of progesterone did not enhance the beneficial effect of E(2) alone. Consistent with our in vivo findings, EtOH stimulated RANKL mRNA expression in cultured primary osteoblasts, and this expression was blocked by 4-methylpyrazole. Acetaldehyde also induced RANKL expression. Class 1 alcohol dehydrogenase was found to be expressed and EtOH-inducible in cultured osteoblasts, whereas CYP2E1 was undetectable. We found that EtOH induced phosphorylation of extracellular signal-regulated kinase (ERK) and signal transducers and activators of transcription 3 (STAT3). E(2) and the mitogenactivated protein kinase kinase inhibitor 2'-amino-3'-methoxyflavone (PD98059) blocked ERK and STAT3 phosphorylation and blocked RANKL induction. Moreover, E(2) completely blocked EtOH-induced osteoclastogenesis in a primary osteoblast and osteoclast precursor coculture system. The E(2) effects were estrogen receptor-mediated. Therefore, E(2) prevents EtOH-induced bone loss by opposing the induction of RANKL mRNA in osteoblasts and ethanol-induced osteoclastogenesis, through opposing effects on sustained ERK signaling.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0022-3565
pubmed:author
pubmed:issnType
Print
pubmed:volume
319
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1182-90
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:16971503-Animals, pubmed-meshheading:16971503-Biological Markers, pubmed-meshheading:16971503-Blotting, Western, pubmed-meshheading:16971503-Bone Marrow, pubmed-meshheading:16971503-Bone Resorption, pubmed-meshheading:16971503-Cells, Cultured, pubmed-meshheading:16971503-Central Nervous System Depressants, pubmed-meshheading:16971503-Estradiol, pubmed-meshheading:16971503-Ethanol, pubmed-meshheading:16971503-Extracellular Signal-Regulated MAP Kinases, pubmed-meshheading:16971503-Female, pubmed-meshheading:16971503-Gene Expression, pubmed-meshheading:16971503-Lymphocyte Activation, pubmed-meshheading:16971503-NF-kappa B, pubmed-meshheading:16971503-Osteoblasts, pubmed-meshheading:16971503-Osteoclasts, pubmed-meshheading:16971503-Pregnancy, pubmed-meshheading:16971503-Progesterone, pubmed-meshheading:16971503-RANK Ligand, pubmed-meshheading:16971503-Rats, pubmed-meshheading:16971503-Rats, Sprague-Dawley, pubmed-meshheading:16971503-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:16971503-Signal Transduction, pubmed-meshheading:16971503-Tomography, X-Ray Computed, pubmed-meshheading:16971503-Up-Regulation
pubmed:year
2006
pubmed:articleTitle
Estradiol protects against ethanol-induced bone loss by inhibiting up-regulation of receptor activator of nuclear factor-kappaB ligand in osteoblasts.
pubmed:affiliation
Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural